These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16997137)

  • 1. Chemogenomics: structuring the drug discovery process to gene families.
    Harris CJ; Stevens AP
    Drug Discov Today; 2006 Oct; 11(19-20):880-8. PubMed ID: 16997137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound library design for target families.
    Balakin KV; Ivanenkov YA; Savchuk NP
    Methods Mol Biol; 2009; 575():21-46. PubMed ID: 19727610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel drug discovery and molecular biological methods, via DNA, RNA and protein changes using structure-function transitions: Transitional structural chemogenomics, transitional structural chemoproteomics and novel multi-stranded nucleic acid microarray.
    Gagna CE; Lambert WC
    Med Hypotheses; 2006; 67(5):1099-114. PubMed ID: 16828979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doing more than just the structure-structural genomics in kinase drug discovery.
    Marsden BD; Knapp S
    Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era.
    Frye SV
    Chem Biol; 1999 Jan; 6(1):R3-7. PubMed ID: 9889153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based chemogenomics: analysis of protein family landscapes.
    Pirard B
    Methods Mol Biol; 2009; 575():281-96. PubMed ID: 19727620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemogenomics: drug discovery's panacea?
    Jacoby E
    Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemogenomics approaches to novel target discovery.
    Gaither LA
    Expert Rev Proteomics; 2007 Jun; 4(3):411-9. PubMed ID: 17552925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity assessment of kinase inhibitors: strategies and challenges.
    Luo Y
    Curr Opin Mol Ther; 2005 Jun; 7(3):251-5. PubMed ID: 15977423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of molecular cancer therapeutics.
    van Montfort RL; Workman P
    Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A-kinase anchoring proteins: trafficking in G-protein-coupled receptors and the proteins that regulate receptor biology.
    Malbon CC
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):573-9. PubMed ID: 17786856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural genomics and drug discovery: all in the family.
    Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
    Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.
    Presland J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advance in the research and discovery of novel drugs based on chemogenomics].
    He BK; Ma ZC; Wang YG; Gao Y
    Yao Xue Xue Bao; 2008 Nov; 43(11):1077-81. PubMed ID: 19239023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases.
    Nidhi ; Glick M; Davies JW; Jenkins JL
    J Chem Inf Model; 2006; 46(3):1124-33. PubMed ID: 16711732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural genomics on membrane proteins: the MePNet approach.
    Lundstrom K
    Curr Opin Drug Discov Devel; 2004 May; 7(3):342-6. PubMed ID: 15216938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.